期刊文献+

Correlations Between Serum Uric Acid Level and Disease Activity,Intrathecal Inflammation Reactivity in Patients with Multiple Sclerosis 被引量:3

Correlations Between Serum Uric Acid Level and Disease Activity,Intrathecal Inflammation Reactivity in Patients with Multiple Sclerosis
下载PDF
导出
摘要 Objective To explore the correlations between serum uric acid(UA) levels and the clinical and cerebrospinal fluid(CSF) parameters of multiple sclerosis(MS).Methods The medical reports of 47 MS patients admitted to Peking Union Medical College Hospital during 2008 and 2010 were reviewed.And 49 age-and gender-matched cerebral infarction patients were enrolled as control.The mean serum UA level of the MS patients was compared with that of the control group.The correlations between the UA levels and the clinical parameters including gender,disease duration,relapse rate,and disease disabilities as assessed by the Expanded Disability Status Scale score,were explored.Forty-one patients had CSF examinations.The correlations between the UA levels and the CSF parameters reflecting inflammation and tissue damage,including CSF protein,white blood cell count,oligoclonal band,24-hour IgG index,and myelin basic protein,were also investigated.Results The mean serum UA level in the MS patients was lower than that in the control group(247.75 ± 52.59 μmol/L vs.277.94 ± 74.33 μmol/L,P=0.025) and inversely correlated with the relapse rate(P=0.049).MS patients with lower serum UA levels tended to have higher white blood cell counts and myelin basic protein level.But there was no correlation between CSF protein levels(r=0.165,P=0.273),white blood cell counts(r=-0.051,P=0.732),IgG index(r =0.045,P=0.802),or myelin basic protein level(r =-0.248,P=0.145) and the serum UA level,respectively.Conclusion In MS patients,UA levels might partly reflect the extent of disability and inflammation. Objective To explore the correlations between serum uric acid (HA) levels and the clinical and cerebrospinal fluid (CSF) parameters of multiple sclerosis (MS). Methods The medical reports of 47 MS patients admitted to Peking Union Medical College Hospi- tal during 2008 and 2010 were reviewed. And 49 age- and gender-matched cerebral infarction patients were enrolled as control. The mean serum HA level of the MS patients was compared with that of the control group. The correlations between the HA levels and the clinical parameters including gender, disease duration, relapse rate, and disease disabilities as assessed by the Expanded Disability Status Scale score, were explored. Forty-one patients had CSF examinations. The correlations between the IdA levels and the CSF parameters reflecting inflammation and tissue damage, including CSF protein, white blood cell count, oligoclonal band, 24-hour IgG index, and myelin basic protein, were also investigated. Results The mean serum HA level in the MS patients was lower than that in the control group (247.75 ± 52.59 jamol/L vs. 277.94 ± 74.33 pmol/L, P=0.025) and inversely correlated with the relapse rate (P=0.049). MS patients with lower serum UA levels tended to have higher white blood cell counts and myelin basic protein level. But there was no correlation between CSF protein levels (r=0.165, P=0.273), white blood cell counts (r=-0.051, P=0.732), IgG index (r =0. 045, P=0.802), or myelin basic protein level (r =-0.248, P=0.145) and the serum UA level, respectively. Conclusion In MS patients, UA levels might partly reflect the extent of disability and inflammation.
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2012年第2期88-91,共4页 中国医学科学杂志(英文版)
关键词 多发性硬化 炎症反应 酸水 患者 血清 疾病 尿酸 髓鞘碱性蛋白 uric acid multiple sclerosis relapse rate cerebrospinal fluid
  • 相关文献

参考文献14

  • 1Scott GS, Hooper DC. The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypotheses 2001; 56:95-100.
  • 2Hooper DC, Bagasra O, Marini JC, et al. Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528-33.
  • 3Toncev G, Milicic B, Toncev S, et al. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur ] Neurol 2002, 9:221-6.
  • 4Rentzos M, Nikolaou C, Anagnostouli M, et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 2006; 108:527-31.
  • 5Knapp CM, Constantinescu CS, Tan JH, et al. Serum uric acid levels in optic neuritis. Mult Scler 2004; 10:278-80.
  • 6Peng F, Zhang B, Zhong X, et al. Serum uric acid levels of patients with multiple sclerosis and other neurological diseases. Mult Scler 2008; 14:188-96.
  • 7Mostert JP, Ramsaransing GSM, Heersema DJ, et al. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses. J Neurol Sci 2005; 231:41-4.
  • 8Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
  • 9Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58:840-6.
  • 10Sotgiu S, Pugliatti M, Sanna A, et al. Serum uric acid and multiple sclerosis. Neurol Sci 2002; 23:183-8.

同被引文献22

  • 1Raf Brouns,Annick Wauters,Gerda Van De Vijver,Didier De Surgeloose,Rishi Sheorajpanday,Peter P. De Deyn.Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome[J].Clinical Chemistry and Laboratory Medicine.2010(3)
  • 2Christopher J. Weir,Scott W. Muir,Matthew R. Walters,Kennedy R. Lees.Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute Stroke[J].Stroke: Journal of the American Heart Association.2003(8)
  • 3Weisskopf M G,O’Reilly E,Chen H,Schwarzschild M A,Ascherio A.Plasma urate and risk of Parkinson’s disease. American Journal of Epidemiology . 2007
  • 4Kieburtz K.,Hyson C.,Gorbold E.,Rudolph A.,Fahn S.,Gauger L.,Goetz C.,Marek K.,Seibyl J.,Forrest M.,Ondrasik J.,Schwarzschild M.A.,Ascherio A.,Schwid S.R.,Watts A.,Oakes D.,Shoulson I.,Lang A.E.Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Archives of Neurology . 2008
  • 5Markowitz CE,Spitsin S,Zimmerman V,et al.The treatment of mul-tiple sclerosis with inosine. Journal of Alternative and Complementary Medicine . 2009
  • 6Jelena Drulovi?,Irena Dujmovi?,Neboj?a Stojsavljevi?,?arlota Mesaro?,Slobodanka Andjelkovi?,Djordje Miljkovi?,Vesna Peri?,Gradimir Dragutinovi?,Jelena Marinkovi?,Zvonimir Levi?,Marija Mostarica Stojkovi?.??Uric acid levels in sera from patients with multiple sclerosis(J)Journal of Neurology . 2001 (2)
  • 7ángel Chamorro,Victor Obach,álvaro Cervera,Marian Revilla,Ramón Deulofeu,John H. Aponte.??Prognostic Significance of Uric Acid Serum Concentration in Patients With Acute Ischemic Stroke(J)Stroke: Journal of the American Heart Association . 2002 (4)
  • 8Chen Jiunn-Horng,Chuang Shao-Yuan,Chen Hsin-Jen,Yeh Wen-Ting,Pan Wen-Harn.Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis and Rheumatism . 2009
  • 9Sara Cipriani,Xiqun Chen,Michael A Schwarzschild.??Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosis(J)Biomarkers Med. . 2010 (5)
  • 10J.‐H. Min,P. Waters,A. Vincent,S. Lee,H. Y. Shin,K. H. Lee,B. J. Kim.??Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO(J)Acta Neurol Scand . 2012 (4)

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部